| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |